Psychedelic Therapy Training for Physicians

Psychedelic Therapy Training Program for Physicians & Prescribers

Embark on a transformative journey with our Psychedelic Therapy Training Program, designed specifically for physicians and prescribers.

This comprehensive course leverages the innovative potential of psychedelic medicine to foster deep connections with oneself, others, and the world.

Enroll Now - $1897

Depending on your location, options to spread your payments will be available on the checkout page.

Course curriculum

Led by ATMA, a pioneer in legal psychedelic-assisted therapy in Canada, the program offers 126 lessons and 14.5 hours of video content, equipping medical professionals with the knowledge and skills to integrate psychedelic therapies into their practice. Discover a new frontier in healing and personal growth.

1. Welcome!
2. Mark Haden
3. Dr. Devon Christie
4. Bruce Sanguin
5. Saundra Jain
6. Dr. Rakesh Jain
7. Dr. Anthony Bossis
8. Kim Haxton
9. Dr. Ben Malcolm
10. Alex Belser
11. Dr. Pam Kryskow
12. Zach Walsh
13. Dr. Ravinder Bains
14. Dr. Monika Hooper
1. M1 Overview: Psychedelics are Medicine - Mark Haden
2. M1 Overview: The Categories of Psychedelics - Mark Haden
3. M1 Overview: Psychedelics - Nature vs Lab - Dr. Rakesh Jain
4. M1 Overview: Are manmade compounds missing out on the full spectrum of what nature can provide? - Dr. Rakesh Jain
5. M1 Overview: The Benefits of the Psychedelic Experience - Alex Belser
6. M1 Overview: Psychedelics and the Prescriber - Monika Hooper
7. M1 Overview: Psychedelics in the Context of Holistic Psychiatric Care - Monika Hooper
8. M1 History: History Of Psychedelics - Mark Haden
9. M1: History: Untold History Of Psychedelics - Mark Haden
10. M1 Current Study and Research of Psychedelics: Section 56 Exemptions, SAP and Trials-Accessing Psychedelics - Mark Haden
11. M1 Current Study and Research of Psychedelics: Microdosing Psychedelics - Zach Walsh
12. M1 BONUS MATERIAL: Current Study and Research of Psychedelics: Microdosing Survey Outcomes - Zach Walsh
13. M1 Current Study and Research of Psychedelics: Psychedelics and Wellness Study 2019 - Saundra Jain
1. M2 The Psychedelic Medicines-Types and Descriptions: Psilocybin - Mark Haden
2. M2 The Psychedelic Medicines-Types and Descriptions: MDMA - Mark Haden
3. M2 The Psychedelic Medicines-Types and Descriptions: MDMA and Psilocybin-Clinical Indications - Alex Belser
4. M2 The Psychedelic Medicines-Types and Descriptions: DMT and 5-MeO-DMT - Mark Haden
5. M2 BONUS MATERIAL: The Psychedelic Medicines-Types and Descriptions: 2C-B - Mark Haden
6. M2 BONUS MATERIAL: The Psychedelic Medicines-Types and Descriptions: 3-MMC - Mark Haden
7. M2 The Psychedelic Medicines-Types and Descriptions: LSD - Mark Haden
8. M2 BONUS MATERIAL: The Psychedelic Medicines-Types and Descriptions : MEAI - Mark Haden
9. M2 The Psychedelic Medicines-Types and Descriptions: Ketamine - Uses and Benefits - Rakesh Jain
10. M2 The Psychedelic Medicines-Types and Descriptions: Maximizing The Benefits in Ketamine Application - Dr. Rakesh Jain
11. M2 The Psychedelic Medicines-Types and Descriptions: Psychedelics And The Four Neurotransmitters - Dr Rakesh Jain
12. M2 The Psychedelic Medicines-Types and Descriptions: Comparing Effects and Outcomes of Psilocybin, MDMA and Ketamine Therapy - Zach Walsh
13. M2 The Psychedelic Medicines-Neurobiology: Pharmacology in Relation to Psychedelics - Ben Malcolm
14. M2 The Psychedelic Medicines-Neurobiology: Neurobiology and Effects of Psychedelics - Ben Malcolm
15. M2 The Psychedelic Medicines-Neurobiology: Leading Theories in Neurobiology for Psychedelics - Ben Malcolm
16. M2 The Psychedelic Medicines-Neurobiology: Overview of MDMA - Ben Malcolm
17. M2 The Psychedelic Medicines-Neurobiology: MDMA Side Effects - Ben Malcolm
18. M2 The Psychedelic Medicines-Neurobiology: MDMA Pharmacodynamics - Ben Malcolm
19. M2 The Psychedelic Medicines-Neurobiology: MDMA Pharmacokinetics - Ben Malcolm
20. M2 The Psychedelic Medicines-Neurobiology : MDMA Drug Interactions - Ben Malcolm
21. M2 The Psychedelic Medicines-Neurobiology: Seratonin Syndrome/Toxicity - Ben Malcolm
22. M2 The Psychedelic Medicines-Neurobiology: Overview of Psilocybin - Ben Malcolm
23. M2 The Psychedelic Medicines-Neurobiology: Psilocybin Pharmacodynamics and Pharmacokinetics - Ben Malcolm
24. M2 The Psychedelic Medicines-Neurobiology: Psilocybin Drug Interactions - Ben Malcolm
25. M2 The Psychedelic Medicines-Neurobiology: Ketamine Overview - Ben Malcolm
26. M2 The Psychedelic Medicines-Neurobiology: Ketamine Pharmacodynamics - Ben Malcolm
27. M2 The Psychedelic Medicines-Neurobiology: Ketamine Pharmacokinetics - Ben Malcolm
28. M2 The Psychedelic Medicines-Neurobiology : Ketamine Drug Interactions - Ben Malcolm
29. M2 The Psychedelic Medicines-Neurobiology: Final Thoughts-The Data Will Set Us Free - Ben Malcolm
1. M3 Access and Inclusivity: Indigenous Perspectives - Benefits of Medicine Circles and Individual Ceremonies - Kim Haxton
2. M3 Access and Inclusivity: Indigenous Perspectives - Bridging The Gap With Psychedelics - Kim Haxton
3. M3 Access and Inclusivity: Indigenous Perspectives - Indigenous-Informed Ways to Offer Psychedelics to Diverse Populations - Kim Haxton
4. M3 Access and Inclusivity: Indigenous Perspectives - Settler Reflexivity - Kim Haxton
5. M3 Access for Diverse and Under-privileged Populations: Making a difference in First Nations Communities - Kim Haxton
6. M3 Access for Diverse and Under-privileged Populations: Challenges of Access for Diverse Populations - Kim Haxton
7. M3 Access for Diverse and Under-privileged Populations: Reciprocity - Kim Haxton
8. M3 Access for Diverse and Under-privileged Populations: The Future of Accessibility - Alex Belser
9. M3 Access for Diverse and Under-privileged Populations: The Challenge of Accessibility to Psychedelic Treatments - Monika Hooper
10. M3 Access for Diverse and Under-privileged Populations: The Special Access Program (SAP) Process for Psilicybin and MDMA - Monika Hooper
11. M3 Cultural Considerations: Cross Cultural Considerations - Kim Haxton
12. M3 Cultural Considerations: What We Need To Know About Psychedelics, LGBTQIA+ and BIPOC - Alex Belser
1. M4 The Therapeutic Facilitator: The Role of a Prescriber in Referring to a PaT Facilitator - Rakesh Jain
2. M4 Basic Principles of Guiding/Sitting: - The Value Of Working Within A Team Of Psychedelic Therapists - Pam Kryskow
3. M4 Basic Principles of Guiding/Sitting: A Pragmatic Approach to Trauma-Informed Psychedelic Work - Rakesh Jain
4. M4 Self-Care for the Facilitator: Therapist Support Networks for Self-Care - Saundra Jain
1. M5 Codes of Ethics for Psychedelic-Assisted Therapy: Where To Go For Ethical Guidelines - Saundra Jain
2. M5 Codes of Ethics for Psychedelic-Assisted Therapy: The Importance Of Creating A Code Of Ethics For PaT - Devon Christie
3. M5 Codes of Ethics for Psychedelic-Assisted Therapy: How The 4 Pillars Of Healthcare Ethics Should Inform PaT - Devon Christie
4. M5 Codes of Ethics for Psychedelic-Assisted Therapy: The Ethical Psychedelic Practitioner - Pam Kryskow
5. M5 Consent/Boundaries and Appropriate Touch: Informed Consent In Psychedelic Treatment - Devon Christie
6. M5 Consent/Boundaries and Appropriate Touch: When Touch Is Important And Useful - Devon Christie
7. M5 Consent/Boundaries and Appropriate Touch: Navigating Touch Options for PaT - Devon Christie
8. M5 Harm Reduction - Challenging Situations and Adverse Effects: When Should Harm Reduction Begin? - Rakesh Jain
9. M5 Harm Reduction - Challenging Situations and Adverse Effects: Harm Reduction Principles - Saundra Jain
10. Module 5 Additional Downloadable Resources
1. M6 The Role of Prescriber in Preparing the Patient: Patient Counselling - Ben Malcolm
2. M6 The Role of the Prescriber in Preparation and Integration - Monika Hooper
3. M6 Screening for Safety and Optimal Experiences: Screening for PaT - Red Flags and Green Flags - Mark Haden
4. M6 Screening for Safety and Optimal Experiences: Screening Principles - The Art of Saying No - Rakesh Jain
5. M6 Screening and Safety for Optimal Experiences: Assessing a Patient for Psychedelic Treatment - Monika Hooper
6. M6 Screening for Safety and Optimal Experiences: Psychedelic Screening - Ben Malcolm
7. M6 Preparation Tools: Preparing the Client for Psychedelic Therapy - Ben Malcolm
8. M6 Preparation Tools: Setting Intentions For Psychedelics - Saundra Jain
9. M6 Preparation Tools: Embodied Inquiry In The Preparatory Session - Devon Christie
1. M7 Dosage: Dosing Psychedelics - Ben Malcolm
2. M7 Dosage Considerations: Psychotropics And Psychedelics - Ben Malcolm
3. M7 Dosage Considerations: Prescribing Over-Prescribing De-Prescribing - Rakesh Jain
4. M7 Dosage Considerations: Dosage Considerations for Psilocybin and MDMA - Alex Belser
1. M8 Utilizing Psychedelics: The Paradigm Shift - Comparing and Contrasting Traditional and Psychedelic-Assisted Therapy - Ravi Bains
2. M8 Utilizing Psychedelics: Best Uses for Psychedelics - Ben Malcolm
3. M8 Utilizing Psychedelics: Addictive Potential of Psychedlics - Ben Malcolm
4. M8 Addictions: Psychedelics for Substance Use Disorders - Ben Malcolm
5. M8 Addictions: The Power of Psychedelics for Addiction - Rakesh Jain
6. M8 Palliative Care: Psychedelics for End of Life Distress - Clinical Trials - Anthony Bossis
7. M8 Palliative Care: Screening and Preparation for Palliative Care - Clinical Trials - Anthony Bossis
8. M8 Palliative Care: Medicine Session and Integration for Palliative Care PaT - Clinical Trials - Anthony Bossis
9. M8 The Mystical Side of Psychedelics: Psychedelic Research and the Mystical Experience - Clinical Trials - Anthony Bossis
10. M8 Palliative Care: Psychedelics for End of Life Distress - Clinical Therapy - Ravi Bains
11. M8 Palliative Care: Screening and Preparation Sessions - Clinical Therapy - Ravi Bains
12. M8 Palliative Care: Palliative Care PaT - The Medicine Session- Clinical Therapy - Ravi Bains
13. M8 Palliative Care: Palliative Care PaT - Integrating the Experience - Clinical Therapy - Ravi Bains
14. M8 Palliative Care: Participant Perspective-Benefits of PaT for End-of-Life Distress - Thomas Hartle
15. M8 Mental Wellness: Can Psychedelics Be Used For ADHD? - Rakesh Jain
16. M8 Mental Wellness: OCD And Psychedelics - Rakesh Jain
17. M8 Mental Wellness: Psychedelics for Depression and Anxiety - Rakesh Jain
18. M8 Personality Disorders: Cautionary PaT With Personality Disorders - Mark Haden
1. M9 Integration Overview: The Role of the Prescriber for Preparation and Integration - Rakesh Jain
2. M9 Integration Overview: Integration-What Is It And Why Is It Needed? - Saundra Jain
3. M9 Integration Models: The Elements Of Effective Integration - Rakesh Jain
4. M9 Integration Models: Integrating The Difficult Experience - Rakesh Jain
5. M9 Complementary Modalities for PAT: The Importance Of Multiple Complementary Modalities - Pam Kryskow
6. M9 Complementary Modalities: Third Wave Behaviour Therapies And PaT - Zach Walsh
7. M9 Trauma-Informed Therapy: Psychedelics And Trauma - Rakesh Jain
8. M9 Trauma-Informed Therapy: Rule Of Thirds In Trauma-Informed Psychedelic Therapy - Rakesh Jain
9. M9 Trauma-Informed Therapy: Trauma-Informed Therapy And Psychedelics - Rakesh Jain
10. M9 Trauma-Informed Therapy: A Practical Approach To Trauma-Informed Psychedelic Work - Rakesh Jain
11. M9 Trauma-Informed Therapy: Somatic Approach To Trauma In PaT - Devon Christie
12. M9 Wild 5 Wellness: Humour And Well-Being - Saundra Jain
13. M9 Wild 5 Wellness: Wild 5 Wellness Program - Saundra Jain

About this course

$1,897.00
126 lessons
14.5 hours of video content

Instructor(s)

ATMA Training

ATMA is a Canadian company focused on delivering effective and innovative healing and transformative experiences that leverage the potential of psychedelic medicine to awaken the inner healer and allow a deeper connection with self, with others and with the beauty of our world. ATMA was the first private company in Canada to conduct legal psychedelic-assisted therapy with psilocybin, one of the active hallucinogens found in ‘magic mushrooms’.

Psychedelic Therapy Training Program for Physicians & Prescribers

Course curriculum

Welcome!

Module 1: Psychedelic Foundations

Module 2: The Psychedelic Medicines

Module 3: Access and Inclusivity

Module 4: The Therapeutic Facilitator

Module 5: Ethics and Consent

Module 6: Preparing the Client for Psychedelic Therapy

Module 7: Dosage

Module 8: Diagnosing and Prescribing

Module 9: Integration

About this course

Instructor(s)

ATMA Training